ThermoGenesis designs and manufactures automated, closed‑system technologies for cell‑based therapeutics and bioprocessing. Its platforms streamline manual steps in cell manufacturing, delivering performance gains in mononuclear cell purification, contaminant washing, cell selection and storage while significantly reducing processing times. The solutions support the entire cell therapy workflow—from biobanking and point‑of‑care processing to scalable, clinical‑grade manufacturing—for researchers, clinicians and biomanufacturers.
Funding
$3M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Researchers, clinicians, and biomanufacturers must perform multiple manual steps to purify, wash, select, and cryopreserve stem, immune, and gene‑edited cells, which introduces variability, increases processing time, and raises contamination risk. Scaling these processes from early‑stage research to clinical‑grade manufacturing further compounds the need for consistent, closed‑system automation.
Solution
ThermoGenesis provides closed‑system, automated devices that integrate cell purification, contaminant washing, selection, and cryopreservation into modular platforms. The systems replace manual pipetting and open‑tube handling with sealed, programmable workflows, reducing operator exposure and minimizing contamination. Automated protocols deliver reproducible, clinical‑grade cell products while shortening overall processing times. The platforms support a range of applications—from cord‑blood biobanking to point‑of‑care processing and large‑scale manufacturing—enabling a seamless transition from laboratory research to patient‑specific therapies.
Target Audience
Primary customers are academic and commercial researchers, clinical laboratories, and biomanufacturing organizations developing stem cell, immune cell, or gene‑edited cell therapies.
Features
- Closed, sterile processing chambers that eliminate open‑system handling and reduce contamination risk
- Modular automation modules for mononuclear cell purification, contaminant washing, cell selection, and cryopreservation
- Integrated software that controls and records each step, ensuring traceability and compliance with cGMP standards
- Scalable designs that accommodate both low‑volume research runs and high‑throughput clinical manufacturing
- Compatibility with standard cryogenic storage bags (e.g., Freezing Bag, 3D Bag Set) for seamless downstream storage
- FDA‑registered manufacturing facility support and quality‑management services for regulatory compliance